Obtained chest wall abnormalities
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age 16 years or olderChest wall abnormality of interest for this validation study: a) Chest wall fracture after blunt trauma (one or more rib fractures or sternum fracture (CT confirmed); b) Symptomatic chest wall fracture nonunion (CT confirmed); c) Clinically diagnosed slipping rib syndrome; d) Symptomatic pulmonary herniation based on costal margin rupture and/or rib fracture (nonunion)Provision of informed consent by patient
Exclusion criteria
Exclusion criteria: Severely affected QoL prior to participation (pre-trauma for acute chest wall abnormalities; paraplegia, tetraplegia, quadriplegia, or severe psychological comorbidity for all subgroups)Expected problems with maintaining follow-upInsufficient comprehension of Dutch language to understand the study documents and to complete the questionnaires (even with some help)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome measure is the C-QoL-DLV. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome measures are the measurement properties of C-QoL-DLV. Measurements properties will include factor analysis, reliability (internal consistency), construct validity, floor and ceiling effect, responsiveness (longitudinal validity), effect size, smallest detectable change, (limits of) agreement, and minimal important change, and will be determined using the COnsensus-based Standards for the selection of health Measurement Instruments (COSMIN) guidelines. | — |
Countries
Netherlands
Contacts
Erasmus MC, Universitair Medisch Centrum Rotterdam